GenSight Biologics S.A.
GSGTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 18.4% | -50.9% | -51.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -757.9% | -1,648.8% | -1,036.9% | -515.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -933.4% | -2,069.5% | -1,069.9% | -542.4% |
| EPS Diluted | -0.17 | -0.54 | -0.6 | -0.63 |
| % Growth | 68.5% | 10% | 4.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |